SPIDER
SPIDER is an intervention with 3 clinical trials. Currently 2 active trials ongoing.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
2
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients
Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures
Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting
Clinical Trials (3)
SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients
Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures
Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting
All 3 trials loaded
Drug Details
- Intervention Type
- Varies by study
- Total Trials
- 3